Atlas Trials

Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome

Clinical trial NCT02921893 · COMPLETED

Trial details

NCT number
NCT02921893
Sponsor
Mayo Clinic
Status
COMPLETED
Phase
Early Phase 1
Study type
INTERVENTIONAL
PlasmacytomaPOEMS Syndrome
Start date
2016-10-31
Primary completion
2022-04-21
Enrollment
21

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.